Cargando…

Editorial Comment to Tumor lysis syndrome following cabazitaxel administration for metastatic castration‐resistant prostate cancer: A case report

Detalles Bibliográficos
Autor principal:	Yamamoto, Yoshiyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292127/ https://www.ncbi.nlm.nih.gov/pubmed/32743406 http://dx.doi.org/10.1002/iju5.12080

Ejemplares similares

Tumor lysis syndrome following cabazitaxel administration for metastatic castration‐resistant prostate cancer: A case report
por: Oshima, Masashi, et al.
Publicado: (2019)

Editorial Comment: Overall survival prediction in metastatic castration-resistant prostate cancer treated with radium-223
por: dos Reis, Rodolfo Borges, et al.
Publicado: (2020)

Cabazitaxel multiple rechallenges in metastatic castration‐resistant prostate cancer
por: Pobel, Cedric, et al.
Publicado: (2021)

Olaparib vs Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer
por: Wallis, Christopher J. D., et al.
Publicado: (2021)

Editorial Comment to Castration‐resistant prostate cancer diagnosed during leuprorelin treatment for spinal and bulbar muscular atrophy
por: Pennuto, Maria, et al.
Publicado: (2022)

Editorial Comment to Nonmetastatic castration‐resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy
por: Hirayama, Yukiyoshi, et al.
Publicado: (2021)

Sequencing of Cabazitaxel in Metastatic Castrate-Resistant Prostate Cancer: A Case Report
por: Colbourn, Donald
Publicado: (2012)

Complete Radiologic Response in Metastatic Castration-Resistant Prostate Cancer Treated with Cabazitaxel
por: Mofid, Bahram, et al.
Publicado: (2015)

Prognostic factors in men with metastatic castration-resistant prostate cancer treated with cabazitaxel
por: Belderbos, Bodine P.S., et al.
Publicado: (2017)

The Influence of Prednisone on the Efficacy of Cabazitaxel in Men with Metastatic Castration-Resistant Prostate Cancer
por: Buonerba, Carlo, et al.
Publicado: (2017)

Editorial Comment to Interstitial lung disease induced by apalutamide therapy for castration‐resistant prostate cancer: A report of a rare case
por: Yuasa, Takeshi
Publicado: (2022)

Cabazitaxel versus docetaxel for treatment of metastatic castrate refractory prostate cancer
por: James, Nicholas D., et al.
Publicado: (2022)

Circulating Tumor Cell Enumeration and Characterization in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Cabazitaxel
por: de Kruijff, Ingeborg E., et al.
Publicado: (2019)

Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer
por: Paller, Channing J, et al.
Publicado: (2011)

Cabazitaxel in the treatment of metastatic castration-resistant prostate cancer: patient selection and special considerations
por: Patel, Sheel A, et al.
Publicado: (2017)

Benefit of cabazitaxel in previously treated metastatic castration-resistant prostate cancer; CARD trial
por: Mishra, Ankit
Publicado: (2020)

Safety and efficacy of cabazitaxel in Japanese patients with castration-resistant prostate cancer
por: Yamamoto, Teppei, et al.
Publicado: (2020)

Editorial Comment to Microscopic pulmonary tumor embolism from adenocarcinoma of the prostate
por: Iguchi, Taro, et al.
Publicado: (2020)

Editorial Comment from Dr Hamidi to Cranial nerve palsy caused by metastasis to the skull base in patients with castration‐resistant prostate cancer: Three case reports
por: Hamidi, Nurullah
Publicado: (2021)

Clinical Development of Cabazitaxel for the Treatment of Castration-Resistant Prostate Cancer
por: Tsao, Che-Kai, et al.
Publicado: (2011)

Cabazitaxel for Metastatic Castration-Resistant Prostate Cancer: Retrospective Data Analysis from an Indian Centre
por: Noronha, Vanita, et al.
Publicado: (2016)

Editorial Comment from Dr Hirayama and Dr Iguchi to Cranial nerve palsy caused by metastasis to the skull base in patients with castration‐resistant prostate cancer: Three case reports
por: Hirayama, Yukiyoshi, et al.
Publicado: (2021)

Analysis of cabazitaxel‐resistant mechanism in human castration‐resistant prostate cancer
por: Hongo, Hiroshi, et al.
Publicado: (2018)

National Consensus on Non-metastatic Castration-Resistant Prostate Cancer: more than just a snapshot
por: Reis, Leonardo Oliveira, et al.
Publicado: (2021)

Editorial Comment: Translational research in urology: nutricion and prostate
por: Favorito, Luciano A.
Publicado: (2021)

Editorial Comment to Safety and efficacy of apalutamide in Japanese patients with metastatic castration‐sensitive prostate cancer receiving androgen deprivation therapy: Final report for the Japanese subpopulation analysis of the randomized, placebo‐controlled, phase III TITAN study
por: Zang, Zhijiang, et al.
Publicado: (2022)

Editorial Comment to Prognostic implication of staging of seminal vesicle invasion in patients with prostatic adenocarcinoma after prostatectomy
por: Yamamoto, Shinya
Publicado: (2021)

Editorial Comment to Granulomatous prostatitis with high suspicion of prostatic adenocarcinoma on radiological imaging
por: Sekito, Takanori, et al.
Publicado: (2021)

Cabazitaxel: A novel taxane for metastatic castration-resistant prostate cancer-current implications and future prospects
por: Abidi, Afroz
Publicado: (2013)

Editorial Comment
por: Madbouly, Khaled
Publicado: (2011)

EDITORIAL COMMENT
por: Mladenov, Dimitar
Publicado: (2013)

EDITORIAL COMMENT
por: Gibas, Artur
Publicado: (2013)

EDITORIAL COMMENT
por: Salagierski, Maciej
Publicado: (2013)

EDITORIAL COMMENT
por: Tiu, Albert, et al.
Publicado: (2013)

EDITORIAL COMMENT
por: Poletajew, Sławomir, et al.
Publicado: (2013)

EDITORIAL COMMENT
por: Oszukowska, Elżbieta
Publicado: (2013)

EDITORIAL COMMENT
por: Matuszewski, Marcin
Publicado: (2013)

EDITORIAL COMMENT
por: Świniarski, Piotr Paweł
Publicado: (2013)

EDITORIAL COMMENT
por: Apoznański, Wojciech
Publicado: (2013)

Editorial Comment
por: Goel, Apul
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8h2sra7qb72la1bc0mfavhsfue